MedTrace Logo

Dermatologic Tacrolimus Ointment on Eyelids in the Treatment of Refractory Vernal Keratoconjunctivitis and Atopic Keratoconjunctivitis

NCT03557203 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2018-06-14

No results posted yet for this study

Summary

To evaluate the therapeutic effects of dermatologic tacrolimus ointment on eyelids to treat refractory vernal keratoconjunctivitis and atopic keratoconjunctivitis.

Conditions

  • Vernal Keratoconjunctivitis
  • Atopic Keratoconjunctivitis
  • Tacrolimus

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • I-Jong Wang, professor · National Taiwan University Hospital

Eligibility

Min Age
7 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-01
Primary Completion
2019-05-31
Completion
2019-05-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03557203 on ClinicalTrials.gov